Free Trial

Arch Venture Management, LLC Top Holdings and 13F Report (2024)

About Arch Venture Management, LLC

Investment Activity

  • Arch Venture Management, LLC has $260.56 million in total holdings as of September 30, 2024.
  • Arch Venture Management, LLC owns shares of 9 different stocks, but just 3 companies or ETFs make up 80% of its holdings.
  • About 5.72% of the portfolio was sold this quarter.
  • This quarter, Arch Venture Management, LLC has purchased 9 new stocks and bought additional shares in 0 stocks.
  • Arch Venture Management, LLC sold shares of 1 stock and completely divested from 0 stocks this quarter.

Largest Holdings

Beam Therapeutics
$118,448,999
RAPPORT THERAPEUTICS, INC.
$76,364,554
Erasca
$30,181,662
Q32 BIO INC.
$14,299,907

Largest Sales this Quarter

Beam Therapeutics
608,386 shares (about $14.91M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofArch Venture Management, LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$118,448,999$14,905,457 -11.2%4,834,65345.5%Medical
RAPPORT THERAPEUTICS, INC.
$76,364,5540.0%3,728,73829.3%COM
Erasca, Inc. stock logo
ERAS
Erasca
$30,181,6620.0%11,055,55411.6%Medical
Q32 BIO INC.
$14,299,9070.0%320,4825.5%COM
Verve Therapeutics, Inc. stock logo
VERV
Verve Therapeutics
$9,722,6360.0%2,008,8093.7%Medical
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
$7,946,3560.0%8,055,9163.0%Medical
SINGULAR GENOMICS SYSTEMS, INC.
$1,984,2920.0%126,6300.8%COM NEW
Unity Biotechnology, Inc. stock logo
UBX
Unity Biotechnology
$1,477,0810.0%1,004,8170.6%Medical
Phoenix Biotech Acquisition Corp. stock logo
PBAX
Phoenix Biotech Acquisition
$134,7530.0%1,444,2960.1%Unclassified

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data